Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung cancer

By afschroeder • October 14, 2025

Chan AA, Sankar K, Reckamp KL, Díaz B, Lee DJ. Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung cancer. Sci Rep. 2025 Oct 13;15(1):35597. doi: 10.1038/s41598-025-11897-9. PMID: 41083501.

Tags: Cedars Sinai DoM, Dermatology, Harbor UCLA, Hematology/Oncology, Lung adenocarcinoma, NMT1, Publications, survival, The Cancer Genome Atlas, TIMM17A

Single-cell and spatial omics in liver identify cell-cell communication regulators in aging and insulin resistance

Zhao W, Jiao X, Du K, Sun Q, Duan J, Cao Y, Shen X, Said Z, Karri SS, Ellsworth P, Hu W, Sargsyan A, Astapova[...]

A Multi-Analyte cfDNA-based Blood Test for Early Detection of Hepatocellular Carcinoma

Taggart DJ, Mahajan S, Gallant MA, Pinkoviezky I, Xu J, Sorg AJ, Roberts CC, Slinkov D, Gorospe EC, Mubarak A, Bhandari BR, Freilich B, Gunn[...]

The Epidemiology of Young-Onset Barrett’s Esophagus in the United States: A National Population-Based Study Using the TriNetX Database

Vasireddy AR, Chandar AK, Maravillas MA, Perez JA, Algarin Perneth SL, Kolb JM, Leggett CL, Katzka DA, Iyer PG, Gaddam S, Kamboj AK. The Epidemiology[...]